Etonic Worldwide

Eton Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing innovative treatments for rare diseases, with a particular emphasis on pediatric populations. The company utilizes the FDA's 505(b)(2) regulatory pathway to bring improved formulations of established molecules to market, addressing unmet needs in niche therapeutic areas. Its commercial portfolio includes treatments for adrenal insufficiency, metabolic disorders like cystinosis and homocystinuria, and neurological conditions. Eton aims to provide high-quality, accessible therapies for patients with orphan diseases through strategic acquisitions and internal development.